REQUEST A DEMO
Total
USD $0.00
Search more companies

Cell-Path Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Cell-Path Sp. z o.o. Profile Updated: May 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Cell-Path Sp. z o.o. is based in Poland. The head office is in Gryfice. It operates in the All Other Miscellaneous Ambulatory Health Care Services industry. It was incorporated on January 03, 2023. There was a net sales revenue increase of 100.05% reported in Cell-Path Sp. z o.o.’s latest financial highlights for 2024. During that time, Cell-Path Sp. z o.o.’s total assets grew by 112.52%.

Headquarters
Ul. Kosciuszki 23/6
Gryfice; Zachodniopomorskie; Postal Code: 72-300

Contact Details: Purchase the Cell-Path Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Cell-Path Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Cell-Path Sp. z o.o. report to view the information.
Incorporation Date:
January 03, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Cell-Path Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
100.05%
Total operating revenue
100.05%
Operating profit (EBIT)
3657.13%
EBITDA
1392.41%
Net Profit (Loss) for the Period
N/A
Total assets
112.52%
Total equity
15434.78%
Operating Profit Margin (ROS)
33.08%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?